Atrium Therapeutics, Inc. (RNA)

Typically moves ±0.45% on earnings
EARNINGS ANALYTICS
search

Atrium Therapeutics, Inc. (RNA) has only 1 recorded earnings event on file, so its post-earnings track record is limited. Its biggest recorded post-earnings gain was -0.45% (May 14, 2026) and its biggest decline was -0.45% (May 14, 2026).

Earnings reactions

How RNA moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

1

Avg Abs. Movement

±0.45%

Positive %

0.0%

Negative %

100.0%

Historical Earnings Statistics

Date Timing Earnings move SEC Filing
May 14, 2026 ☽ POST -0.45% open_in_new
event

Earnings Count

1

Total earnings in dataset

trending_up

Avg Abs. Movement

±0.45%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Mar 31, 2026 · SEC 13-F

View all 16 →
16
Funds holding
$35099768
Total value held
Buying
16 added · 0 reduced
Blackrock, Inc.
$16114735 NEW BUY
Goldman Sachs Group Inc
$4678831 NEW BUY
State Street Corp
$3437240 NEW BUY
Morgan Stanley
$2206541 NEW BUY
Janus Henderson Group Plc
$1871370 NEW BUY

SEC Filing Types

Recent SEC Filings

10 most recent
Form Date Filed View on EDGAR
8-K 20260714 open_in_new SEC.gov
SCHEDULE 13G 20260515 open_in_new SEC.gov
10-Q 20260514 open_in_new SEC.gov
8-K 20260514 open_in_new SEC.gov
SCHEDULE 13G 20260427 open_in_new SEC.gov
SCHEDULE 13G 20260427 open_in_new SEC.gov
4 20260422 open_in_new SEC.gov
4 20260422 open_in_new SEC.gov
4 20260422 open_in_new SEC.gov
4 20260422 open_in_new SEC.gov

Frequently asked about RNA earnings

How much does RNA stock move after earnings? expand_more

Over 1 reports, RNA has moved an average of ±0.45% the session after earnings, closing higher 0.0% of the time.

What was RNA's biggest post-earnings move? expand_more

RNA's largest post-earnings gain on record was -0.45% on May 14, 2026, and its largest decline was -0.45% on May 14, 2026.

Where can I find Atrium Therapeutics, Inc.'s SEC filings? expand_more

All of Atrium Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.

Sector peers